Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Aarey Drugs & Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 161.48 P/BV 1.21 Book Value ( ₹ ) 46.93
52 Week High/Low ( ₹ ) 75/31 FV/ML 10/1 P/E(X) 40.13
Book Closure 30/09/2024 EPS ( ₹ ) 1.42 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]473.94395.62418.96492.68348.42
Total Operating Revenues473.94395.62418.96492.68348.42
      
Other Income9.816.962.732.757.01
Total Revenue483.76402.58421.69495.43355.43
      
EXPENSES     
Cost Of Materials Consumed472.870.000.000.000.00
Purchase Of Stock-In Trade0.00387.76418.98467.29339.25
Changes In Inventories Of FG,WIP And Stock-In Trade-10.80-5.86-15.144.78-1.46
Employee Benefit Expenses0.810.720.810.980.40
Finance Costs4.024.382.872.002.43
Depreciation And Amortisation Expenses1.941.701.571.990.92
Other Expenses8.838.556.588.375.59
Total Expenses477.65397.24415.68485.40347.13
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax6.105.346.0110.038.30
      
Profit/Loss Before Tax6.105.346.0110.038.30
      
Tax Expenses-Continued Operations     
Current Tax2.081.321.782.611.66
Deferred Tax0.00-0.67-0.04-0.110.12
Tax For Earlier Years0.000.000.500.980.00
Total Tax Expenses2.080.662.243.481.79
Profit/Loss After Tax And Before ExtraOrdinary Items4.024.683.776.546.51
      
Profit/Loss From Continuing Operations4.024.683.776.546.51
      
Profit/Loss For The Period4.024.683.776.546.51
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)1.841.671.492.722.79
Diluted EPS (Rs.)1.841.671.492.722.79